An Omicron infection about one year later was clinically mild and characterised by intense stimulation of IgG and IgA antibodies, primarily targeting cross-reactive epitopes of the first infecting virus strain and the vaccine strain, most likely due to immunological memory and immune imprinting [34, 35]. The gene discussed is CD79A; the disease is infection.